BSE filing, BSE: 503635. Summary written from the filing by ALFA Finder's alert engine.
Shree Salasar Investment Ltd: key numbers
- Share price
- ₹298.90
- Market cap
- ₹208.4 Cr
- Revenue (annual)
- ₹112.4 Cr
- Net profit (annual)
- ₹18.25 Cr
- P/E (TTM)
- 9.7×Sector 19.1×
- Promoter holding
- 67.12%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shree Salasar Investment Ltd
All →Shree Salasar Investment Acquisition Worth ₹0.01 Cr
Shree Salasar Investments Limited announced acquiring 51% control of a to-be-incorporated company through subscription of 10,000 shares. The initial cash investment is stated as INR 1,00,000, or 0.01 Crore.
- Value
- ₹0.01 Cr
Shree Salasar Investment Management Change
Shree Salasar Investments Limited appointed Ms. Srishti Shah as Company Secretary and Compliance Officer, effective 23 October 2026, following a board meeting that day. The appointment is a key managerial personnel change.
Shree Salasar Investment Merger & Restructuring Worth ₹0.01 Cr
Board approved up to INR 1 lakh investment in a proposed wholly owned subsidiary and appointed Srishti Shah as Company Secretary. Company also approved a name change.
- Value
- ₹0.01 Cr
Shree Salasar Investment Convertible Warrants
Shree Salasar Investments Limited allotted 18,50,000 warrants at ₹175 each, aggregating ₹32.38 Crore. These warrants are convertible into equity shares within 18 months.
- Value
- ₹32.38 Cr
- Execution
- 18 months
Shree Salasar Investment Other Announcement
The company submitted its quarterly shareholding pattern for the period ending September 30, 2026, as required by SEBI regulations.
Shree Salasar Investment Management Change
Ms. Dashmeet Kaur has resigned as the Company Secretary, Compliance Officer, and Key Managerial Personnel of the company, effective October 9, 2026.
Other fund raise announcements
All →Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr
MosChip Technologies Fund Raise of ₹112.2 Cr
MosChip Technologies approved a preferential issue of 50,50,686 equity shares at Rs.222 to 69 investors, raising about Rs.112.19 Crore. The board approval covers the fund raise, with an AGM/postal ballot dated 25 November 2026.
- Value
- ₹112.2 Cr
Cholamandalam Investment & Finance Company Fund Raise
Cholamandalam's board approved a Qualified Institutions Placement fund raise on 28 October 2026, subject to shareholder postal ballot. The quantum, price and terms remain undetermined.